ABSTRACT
Objective To observe the efficacy and the toxicity of external irradiation combined with 252Cf brachytherapy on advanced cardiac carcinoma.Methods 48 patients with advanced cardiac carcinoma hospitalized during March 2007 to December 2010 were recruited,in which 39 cases were adenocarcinoma,5 patients were squamous carcinoma and 4 cases were signet-ring cell carcinoma.All cases had a Kamofsky above 80,no metastasis and received radiotherapy sequenced external and internal irradiation.The external irradiation was conducted under a 6MV X linear accelerator,and a dose of 38-45 Gy (2 Gy/22 f).The type ZH-1000 252Cf neutron breach-loading machine was used for brachytherapy with a dose of 12-16 Gy.Results Dysphagia cleared in all cases.The short-term efficacy (PR+CR) rate was 91.7 ％ (44/48).One and two year survival rate were,respectively,39.6 ％ and 6.3 ％.25 (52.1％) patients had gastrointestinal symptoms such as nausea,vomiting and impedance,and grade 1,2 neutropenia were occurred in 21 (43.8 ％) and 3 (6.3 ％) patients.Conclusion External irradiation combined with 252Cf brachytherapy is a safe,effective and tolerable treatment for advanced cardiac carcinoma.
ABSTRACT
Objective To evaluate the treatment of advanced endometrial cancer with californium-252 brachytherapy. Methods 21 cases of endometrial cancers who had not received any treatment were diagnosed as in the stages Ⅰ～Ⅳ according to the criteria of FIGO. Treatment schedule included: 252Cf brachytherapy, 8～12Gy/fraction/week, the total dose of reference point A was 35～45 Gy and total dose of reference point F was 35～50Gy in three to four implant sessions. On the second day after 252Cf therapy, the whole pelvis was treated with 6MV X-ray external beam radiotherapy, 200 cGy per fraction, 4 times per week. The total dose of external beam radiotherapy was 45 to 50 Gy (the middle of pelvis was shielded with 4cm of lead), and the total treatment time was 5～6weeks. The recent therapeutic effect and complications were observed. Results The average time of complete tumor regression was 25 days, the local control rate was over 90%; the late radioactive complications of bladder and rectum was low during the 5-year follow-up period. Conclusions Combined californium-252 brachytherapy and high energy X-ray external beam radiotherapy may be safe and effective on advanced endometrial cancer.